{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Ramat Gan",
      "state": "",
      "country": "Israel",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "83761",
      "recalling_firm": "LABSTYLE INNOVATIONS",
      "address_1": "7, Derekh Menakhem Begin",
      "address_2": "",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Other",
      "distribution_pattern": "Nationwide domestic distribution. Foreign distribution to Australia, Canada, UK, and Italy.",
      "recall_number": "Z-0260-2020",
      "product_description": "Dario Blood Glucose Monitoring System, Model No. 1015-05, running Android software versions 4.3.0-4.3.2",
      "product_quantity": "126,271 (83,141 US; 43,130 OUS)",
      "reason_for_recall": "The Dario-Blood Glucose Tracker Android App versions 4.3.0-4.3.2 may experience duplicate logging of a blood glucose level reading.",
      "recall_initiation_date": "20190829",
      "center_classification_date": "20191031",
      "termination_date": "20200505",
      "report_date": "20191106",
      "code_info": "Android App Software versions 4.3.0-4.3.2",
      "more_code_info": ""
    }
  ]
}